Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-07-01 @ 3:04 AM
Study NCT ID:
NCT00945334
Status:
COMPLETED
Last Update Posted:
2015-08-10
First Post:
2009-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Sponsor:
Mark Pimentel, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
18709
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |